News

Latest news

Hide mandatory notifications of trade

Binding agreement signed between Bionor Pharma and Axellus regarding sale of the Nutrilett trademarks to Axellus

(Oslo, 22 December 2010)
Bionor Pharma and Orkla-owned Axellus have today signed a binding agreement under which Bionor will transfer the Nutrilett trademarks to Axellus for a consideration of NOK 110 million...

Bionor Pharma and Orkla-owned Axellus have today signed a binding agreement under which Bionor will transfer the Nutrilett trademarks to Axellus for a consideration of NOK 110 million. The binding agreement replaces the Memorandum of Understanding which was signed on 9th December. Closing of the transaction is scheduled to 6th January 2011.